Compounding Lobby Calls FDA’s Marketing Blitz ‘Misleading’

Drug Industry Daily

Feb. 03, 2014

The compounding pharmacy lobby is pushing back against the FDA’s campaign to encourage hospitals to buy compounded drugs only from agency-registered sites as disingenuous and misleading, saying the products aren’t necessarily safer for patients.
Read More